“LL-37”的搜索结果，显示 71-80 项，共有 6974 项

1. Mayo Clinic Cancer Physician Update - March 2026

   Page 1.

2. 外科 - 临床试验- 妙佑医疗国际

   ... 2-year period. The primary objective of the trial is to compare the composite outcome of the all-cause mortality and incidence of acute aortic events ...

3. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Study B9991011 is a multi-center, international, randomized, open label, 2 ... (2) Cohort 2 focuses on ... Go to page 3737 · Go to page 3838 · NextNext Page.

4. 肾病和高血压- 临床试验- 妙佑医疗国际

   Go to page 22 · Go to page 33 · Go to page 44 · NextNext Page. 以下为当前的临床试验。 37 研究肾病和高血压（仅限开放性研究）. 按位置、状态和其他条件筛选该研究 ...

5. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Jacksonville, Fla. This phase I/II trial tests the safety and tolerability of an experimental personalized vaccine when given by itself and with pembrolizumab ...

6. 外科 - 临床试验- 妙佑医疗国际

   ... 2-year period. The primary objective of the trial is to compare the composite outcome of the all-cause mortality and incidence of acute aortic events ...

7. 妙佑医疗国际移植中心- 临床试验

   The purpose of this study is to determine the safety of the SARS-CoV-2 vaccination in patients listed for solid organ transplantation, including heart, lung, ...

8. 外科 - 临床试验- 妙佑医疗国际

   ... 2-year period. The primary objective of the trial is to compare the composite outcome of the all-cause mortality and incidence of acute aortic events ...

9. 外科 - 临床试验- 妙佑医疗国际

   ... 2) alterations in circulating proteins and metabolites indicative of a ... 2) alterations in circulating proteins and metabolites indicative of a ...

10. 外科 - 临床试验- 妙佑医疗国际

    ... 2-year period. The primary objective of the trial is to compare the composite outcome of the all-cause mortality and incidence of acute aortic events ...